-
2023-503174-20-00
4
2022-05-30
KRAS G12C-mutated non-small cell lung cancer
-
2023-507164-39-00
6
2021-12-01
Induction of labour
-
2023-504152-97-00
5
2021-11-26
Generalized Myasthenia Gravis
-
2024-518775-54-00
6
2021-10-05
Rheumatoid arthritis
-
2024-514765-19-01
4
2021-08-12
Lynch syndrome, which is increasing the risk of developing colorectal
-
2024-511246-39-00
1
2021-07-27
Solid tumours with HER2 aberrations
-
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
-
2023-509846-36-00
9
2020-05-29
Advanced Solid Tumors
-
2024-511053-22-00
4
2020-05-04
Primary sclerosing cholangitis (PSC)
-
2023-509847-29-00
7
2020-04-09
Advanced solid tumors
-
2024-517387-37-00
4
2019-12-12
Small abdominal aortic aneurysm (AAA) under active surveillance; 30-49
-
2023-509699-41-00
9
2019-11-22
Recurrent or Refractory Leukemias, Lymphomas, and Solid Tumors
-
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
-
2024-514409-78-01
9
2019-07-26
relapsed / refractory or progressive high risk malignant disease
-
2024-515350-25-01
6
2019-04-12
Acute wheezing/bronchiolitis
-
2023-506857-40-00
5
2019-01-08
Prostate Cancer
-
2023-504917-54-00
5
2018-10-30
Biochemical recurrence after prostate cancer surgery
-
2022-501254-10-00
5
2018-08-24
Advanced tumors
-
2024-514238-19-00
4
2018-03-28
Subjects with advanced solid tumour
-
2024-513299-17-00
6
2017-05-05
Ulcerative colitis
-
2024-519562-48-00
4
2017-01-12
The study will investigate the effect of deferoxamine on the impaired
-
2023-506987-15-00
9
2016-11-17
Metastatic Castration-Resistant Prostate Cancer
-
2023-506027-29-00
5
2014-10-01
Children, adolescents and adults with newly diagnosed diffuse intrinsi
-
2024-518254-16-00
5
2013-03-01
Acute Myeloid Leukemia (Pediatric 0-18 years)